• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地红霉素纸片药敏试验:解释标准和质量控制参数。

Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters.

作者信息

Barry A L, Pfaller M A, Fuchs P C

机构信息

Clinical Microbiology Institute, Tualatin, Oregon 97062.

出版信息

J Antimicrob Chemother. 1993 Mar;31 Suppl C:27-37. doi: 10.1093/jac/31.suppl_c.27.

DOI:10.1093/jac/31.suppl_c.27
PMID:8478310
Abstract

Dirithromycin and its bioactive metabolite (erythromycylamine) were compared in vitro to erythromycin against 450 bacterial isolates. Dirithromycin and erythromycylamine did not differ in their in-vitro activity and the two compounds were additive when combined in equal proportions. Both compounds were active against erythromycin-susceptible bacteria but erythromycin was two to four times more potent on a weight-to-weight basis. Interpretive criteria for dirithromycin were not based on achievable blood concentrations since tissue concentrations may be 20-30 times greater than peak serum levels. Dirithromycin-susceptible strains were those with zones > or = 19 mm in diameter (15 micrograms dirithromycin disc) or MIC < or = 2.0 mg/L and resistance was defined as a zone < or = 15 mm or MIC > or = 8.0 mg/L. Interpretive criteria for testing Haemophilus influenzae on Haemophilus Test Medium (HTM) agar were not defined because of the drug's poor activity in the test system used. Two multi-laboratory studies were also undertaken, one to define quality control limits for disc diffusion tests and the other to define broth microdilution MIC control limits for tests with dirithromycin.

摘要

将地红霉素及其生物活性代谢物(红霉素胺)在体外与红霉素针对450株细菌分离物进行了比较。地红霉素和红霉素胺的体外活性无差异,且当以等比例组合时这两种化合物具有相加作用。两种化合物对红霉素敏感菌均有活性,但按重量计红霉素的效力要高两到四倍。地红霉素的解释标准并非基于可达到的血药浓度,因为组织浓度可能比血清峰值水平高20至30倍。对地红霉素敏感的菌株是指直径大于或等于19毫米(15微克地红霉素纸片)或最低抑菌浓度(MIC)小于或等于2.0毫克/升的菌株,耐药性定义为抑菌圈小于或等于15毫米或MIC大于或等于8.0毫克/升。由于该药物在所使用的测试系统中活性较差,因此未定义在嗜血杆菌测试培养基(HTM)琼脂上检测流感嗜血杆菌的解释标准。还开展了两项多实验室研究,一项用于确定纸片扩散试验的质量控制限度,另一项用于确定用地红霉素进行试验的肉汤微量稀释MIC控制限度。

相似文献

1
Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters.地红霉素纸片药敏试验:解释标准和质量控制参数。
J Antimicrob Chemother. 1993 Mar;31 Suppl C:27-37. doi: 10.1093/jac/31.suppl_c.27.
2
Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.大环内酯类阿奇霉素体外药敏试验的质量控制参数及解释标准。抗菌药物敏感性协作试验组。
Eur J Clin Microbiol Infect Dis. 1989 Jun;8(6):544-9. doi: 10.1007/BF01967477.
3
In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics.地红霉素(LY 237216)的体外活性与其他大环内酯类抗生素活性的比较。
Antimicrob Agents Chemother. 1990 Sep;34(9):1839-42. doi: 10.1128/AAC.34.9.1839.
4
Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.针对流感嗜血杆菌、卡他莫拉菌和肺炎链球菌近期临床分离株对地红霉素进行的体外比较评估,包括培养基补充成分和试验条件对最低抑菌浓度(MIC)结果的影响。
Diagn Microbiol Infect Dis. 1999 Apr;33(4):275-82.
5
Multi-centre collaborative study for the in vitro evaluation of new macrolides dirithromycin and erythromycylamine. Australian Group for Antimicrobial Resistance (AGAR).新型大环内酯类药物地红霉素和红霉素胺体外评价的多中心协作研究。澳大利亚抗菌药物耐药性研究小组(AGAR)。
Pathology. 1995 Jan;27(1):74-8. doi: 10.1080/00313029500169522.
6
Postantibiotic effect and postantibiotic sub-mic effect of dirithromycin and erythromycin against respiratory tract pathogenic bacteria.地红霉素和红霉素对呼吸道病原菌的抗生素后效应及抗生素后亚抑菌效应
APMIS. 1999 May;107(5):505-13. doi: 10.1111/j.1699-0463.1999.tb01586.x.
7
Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin.新型大环内酯类抗生素地红霉素(AS-E 136;LY237216)的合成及抗菌活性评价,地红霉素系由红霉素衍生而来。
Antimicrob Agents Chemother. 1991 Jun;35(6):1116-26. doi: 10.1128/AAC.35.6.1116.
8
In vitro activity of dirithromycin against Chlamydia trachomatis.地红霉素对沙眼衣原体的体外活性
Antimicrob Agents Chemother. 1994 Sep;38(9):2213-4. doi: 10.1128/AAC.38.9.2213.
9
New drugs--reports of new drugs recently approved by the FDA. Dirithromycin.新药——美国食品药品监督管理局(FDA)近期批准的新药报告。地红霉素。
Bioorg Med Chem. 1996 Apr;4(4):521-2. doi: 10.1016/0968-0896(96)00052-1.
10
In-vitro activity of dirithromycin in comparison with other new and established macrolides.地红霉素与其他新型及已上市大环内酯类药物的体外活性比较。
J Antimicrob Chemother. 1993 Mar;31 Suppl C:39-49. doi: 10.1093/jac/31.suppl_c.39.

引用本文的文献

1
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.与对红霉素、阿奇霉素、克拉霉素、罗红霉素和克林霉素的敏感性相比,青霉素敏感和耐药肺炎球菌对地红霉素的敏感性。
Antimicrob Agents Chemother. 1997 Sep;41(9):1867-70. doi: 10.1128/AAC.41.9.1867.
2
In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.采用微量稀释法测定临床酵母分离株对三种抗真菌药物的体外敏感性。
Mycopathologia. 1995;130(1):3-9. doi: 10.1007/BF01104343.
3
Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
地红霉素。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1994 Oct;48(4):599-616. doi: 10.2165/00003495-199448040-00008.